COGZF Stock - Cogstate Limited
Unlock GoAI Insights for COGZF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $50.81M | $65.11M | $60.14M | $62.03M | $43.82M |
| Gross Profit | $30.69M | $46.38M | $12.29M | $21.63M | $10.40M |
| Gross Margin | 60.4% | 71.2% | 20.4% | 34.9% | 23.7% |
| Operating Income | $10.80M | $6.17M | $3.41M | $15.09M | $5.14M |
| Net Income | $10.14M | $5.45M | $5.30M | $10.37M | $7.02M |
| Net Margin | 20.0% | 8.4% | 8.8% | 16.7% | 16.0% |
| EPS | $0.06 | $0.05 | $0.03 | $0.06 | $0.04 |
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Visit WebsiteEarnings History & Surprises
COGZFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 18, 2026 | — | — | — | — |
Q1 2025 | Feb 20, 2025 | — | $0.02 | — | — |
Q3 2024 | Aug 21, 2024 | — | $0.02 | — | — |
Q1 2024 | Feb 21, 2024 | — | $0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.00 | — | — |
Q2 2022 | Jun 30, 2022 | $0.02 | $0.02 | -7.5% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.01 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.01 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.01 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.00 | — | — |
Q4 2015 | Dec 31, 2015 | — | $0.02 | — | — |
Latest News
Frequently Asked Questions about COGZF
What is COGZF's current stock price?
What is the analyst price target for COGZF?
What sector is Cogstate Limited in?
What is COGZF's market cap?
Does COGZF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to COGZF for comparison